InvestorsHub Logo
Followers 33
Posts 1608
Boards Moderated 0
Alias Born 10/06/2015

Re: None

Thursday, 08/18/2022 10:22:57 AM

Thursday, August 18, 2022 10:22:57 AM

Post# of 232158
CytoDyn's new management is, indeed, quite new. Didn't expect immediate change (in spite of the initial "goodwill" sp rise), it's going to take some time for Cyrus Arman to - really- get in the game as he only recently immersed himself "in the CytoDyn pool" in mid-July.

And because of potential resistance from BP and more pointed obstructionism via BP's marionette >> the FDA, Arman must be careful not to telegraph his moves.

Still, it looks like the decks have been cleared for action (people, product, vectors overboard), some ammunition (in the form of shares) has been taken on, and now we have to be patient.

President Arman has a powerful, though to BP - potentially scary - product, with a unique MOA and plenty of potential applications individually and as an adjuvent. Let's see if he can surprise everyone with some astute "moves."

The game has yet to begin. Hopefully President Arman will impress us with his acumen and adroit strategy(s).

In the meantime, I'm pleased current CYDY bigwigs are being remunerated in shares - definitely keeps them on their toes and in the game.

Looking forward to some pleasant surprises.

IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News